Child Neurology: Hemiconvulsion-Hemiplegia-Epilepsy Syndrome in the Setting of COVID-19 Infection and Multisystem

Paul Gong1, Cemal Karakas2, Bethanie Morgan2

  • 1From the Division of Child Neurology (P.G., C.K., B.M.), Department of Neurology, Universtiy of Louisville; and Norton Children's Medical Group (C.K., B.M.), Louisville, KY. paul.gong@louisville.edu.

Neurology
|August 25, 2022
PubMed

Insights

Hemiconvulsion-hemiplegia-epilepsy (HHE) syndrome, a rare pediatric condition, was observed in a child with COVID-19 and MIS-C. This case highlights a potential new trigger for HHE syndrome in children.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases
  • Epileptology

Background:

  • Hemiconvulsion-hemiplegia-epilepsy (HHE) syndrome is a rare pediatric epilepsy characterized by prolonged focal status epilepticus, hemiplegia, and subsequent epilepsy.
  • The pathophysiology involves hyperthermia, inflammation, and cytotoxic edema, but remains incompletely understood.
  • Prognosis for HHE syndrome varies significantly, ranging from recovery to permanent neurological deficits.

Observation:

  • A 2-year-old boy presented with superrefractory focal status epilepticus during acute COVID-19 and MIS-C.
  • Neurological examination revealed right-sided hemiplegia.
  • Brain MRI demonstrated left cerebral hemispheric edema, consistent with HHE syndrome.

Findings:

  • This case represents the first documented instance of HHE syndrome associated with acute COVID-19 and MIS-C.
  • The findings suggest a potential link between COVID-19, MIS-C, and the development of HHE syndrome.
  • The clinical presentation included severe, prolonged seizures and unilateral cerebral edema.

Implications:

  • This report expands the known triggers for HHE syndrome, suggesting infectious and inflammatory processes like COVID-19 and MIS-C may play a role.
  • Further research is warranted to elucidate the mechanisms linking COVID-19/MIS-C to HHE syndrome.
  • Understanding this association may inform diagnostic and therapeutic strategies for pediatric epilepsy in the context of viral infections.